trimerized apolipoprotein A-I (Borean)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nametrimerized apolipoprotein A-I (Borean)
Drug Alias Nametrimerized ApoA-I (Borean/Proteopharma)trimerized ApoA-I (Borean)trimerized ApoA-I (Proteopharma)trimerized apolipoprotein A-I (Proteopharma)apolipoprotein A-I trimeric (Borean/Proteopharma)
ClassificationBiologics
Mechanisms of ActionApolipoprotein A-I stimulants
TargetsApolipoprotein A-I
Therapy Area/IndicationsInflammationAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmarkSwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesProteopharma APS
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRoche Holding AgBorean Pharma A/SProteopharma APS
Active IndicationsN/A
Inactive IndicationsInflammationAtherosclerosis

Other Information

ATC CodeN/A
Related LinksN/A